Baxion
Screening
Tags
Alerts
Theme
Chemomab Therapeutics Ltd.
CMMB
·
NASDAQ
·
$2.03
Share Price as of 11/2
·
$12M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
20-F
Annual report (foreign)
03/23/26
20-F
Annual report (foreign)
04/04/25
20-F
Annual report (foreign)
03/28/24
10-Q
Q1 ended 03/31/23
05/11/23
10-K
FY 2022
03/20/23
Disclosures
Filter
6-K
Foreign issuer report
10/19/26
6-K
Foreign issuer report
09/30/26
6-K
Foreign issuer report
08/19/26
6-K
Foreign issuer report
07/08/26
6-K
Foreign issuer report
06/02/26
Prospectuses and Registrations
Filter
S-4/A
Registration (business combination, amended)
10/29/26
424B5
Prospectus supplement
07/25/25
POS AM
Post-effective amendment
12/02/24
424B5
Prospectus supplement
11/15/24
424B3
Prospectus
09/09/24
Proxies
Filter
DEFM14A
Definitive proxy (merger)
10/30/26
DEFA14A
Additional proxy materials
05/31/22
DEF 14A
Definitive proxy
04/28/22
DEF 14A
Definitive proxy
01/05/22
PRE 14A
Preliminary proxy
12/23/21
Ownership
Filter
SC 13D/A
Beneficial ownership (amended)
09/09/26
Form 4
Insider transaction
09/01/26
SC 13G
Beneficial ownership
08/13/26
SC 13G/A
Beneficial ownership (amended)
08/10/26
SC 13D
Beneficial ownership
07/16/26
Other
Filter
DRS
DRS
08/12/26
EFFECT
Request for effectiveness
12/10/24
EFFECT
Request for effectiveness
09/06/24
CORRESP
Correspondence with the SEC
09/04/24
UPLOAD
Letter from the SEC
08/29/24
Latest Filings
Filter
DEFM14A
Definitive proxy (merger)
10/30/26
S-4/A
Registration (business combination, amended)
10/29/26
6-K
Foreign issuer report
10/19/26
6-K
Foreign issuer report
09/30/26
6-K
Foreign issuer report
08/19/26
Ownership
Filter
SC 13D/A
Beneficial ownership (amended)
09/09/26
Form 4
Insider transaction
09/01/26
SC 13G
Beneficial ownership
08/13/26
SC 13G/A
Beneficial ownership (amended)
08/10/26
SC 13D
Beneficial ownership
07/16/26